Medical research partners

Independent research after the effects of Dry Salt Aerosol inhalation on a variety of target groups is needed to further extend the knowledge about Dry Salt Aerosol inhalation therapy and create awareness of what the therapy could offer to people.

Since the summer of 2009, Microsalt collaborates with the clinical university in Tübingen, Germany. With a vast knowledge available if it comes to inhalation applications in various formats, the university is equipped well to seriously perform research on Dry Salt Aerosol inhalation.

Early 2010, the university has finalized a research to assess the effects of Dry Salt Aerosol inhalation on a group of people suffering from cystic fibrosis. The patients inhaled dry salt aerosol during 1 hour per day, 7 days in a row. Before, immediately after and 2 hours after the inhalation session, lung functions and obstruction values were measured. In addition, mucus was collected of each patient up to 6 hours after the inhalation session, and examined in the clinical lab.

Based on the findings of the above research, additional as well as new researches and tests are being developed. With future findings about halotherapy, Microsalt strives to create more awarenes among (para)medical professionals in order to make halotherapy accessable to more people who could use a supportive inhalation therapy to treat their respiratory system.